De Wit H
~ AlphaMD Sermorelin is gaining attention in the wellness and hormone therapy space for its potential to support healthier aging, boost energy levels, and improve recovery without some of the risks associated with traditional growth hormone therapy
Generally, GLP-1 agonist medications are FDA approved for adults aged 18 years and older with certain body mass indexes (BMI) (typically a BMI of 30 or above, or a BMI of 27 or above if you have a weight-related health condition such as hypertension, high cholesterol, weight-related anxiety, liver disease, sleep apnea or PCOS)
This meta-analysis found that GLP1RA reduced all-cause mortality by 12%, and adverse renal outcomes by 17% (63)
Eating a balanced diet is also key to keeping your urinary system healthy
P4425 - Hyperkinetic Biliary Dyskinesia Following Discontinuation of GLP-1 Receptor Agonist Therapy, ACG 2025 Annual Scientific Meeting Abstracts